Contraception
Volume 81, Issue 2 , Pages 165-171 , February 2010

Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials

  • Jeffrey T. Jensen

      Affiliations

    • Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    • Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA
    • Corresponding Author InformationCorresponding author. Department of Obstetrics and Gynecology, mail code UHN-70 Oregon Health and Science University, Portland, OR 97239, USA. Tel.: +1 503 494 4469; fax: +1 503 494 5083.
    • ,
  • Richard L. Stouffer

      Affiliations

    • Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA
    • ,
  • Jessica E. Stanley

      Affiliations

    • Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA
    • ,
  • Mary B. Zelinski

      Affiliations

    • Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA

Received 21 July 2009 ,Revised 28 September 2009 ,Accepted 30 September 2009.

References 

  1. Chandra A, Martinez GM, Mosher WD, et al. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital and Health Statistics. 2005;1–160
  2. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38:90–96
  3. Peipert JF, Gutmann J. Oral contraceptive risk assessment: a survey of 247 educated women. Obstet and Gyneco. 1993;82:112–117
  4. Conti M, Andersen CB, Richard F, et al. Role of cyclic nucleotide signaling in oocyte maturation. Mol Cell Endocrinol. 2002;187:153–159
  5. Tsafriri A, Chun SY, Zhang R, et al. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Develop Biol (Orlando). 1996;178:393–402
  6. Conti M, Andersen CB, Richard FJ, et al. Role of cyclic nucleotide phosphodiesterases in resumption of meiosis. Molec Cell Endocrinol. 1998;145:9–14
  7. Mayes MA, Sirard MA. Effect of type 3 and type 4 phosphodiesterase inhibitors on the maintenance of bovine oocytes in meiotic arrest. Biol Reprod. 2002;66:180–184
  8. Wiersma A, Hirsch B, Tsafriri A, et al. Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents. J Clin Invest. 1998;102:532–537
  9. Jensen JT, Schwinof KM, Zelinski-Wooten MB, et al. Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro. Hum Reprod. 2002;17:2079–2084
  10. Nogueira D, Albano C, Adriaenssens T, et al. Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro. Biol Reprod. 2003;69:1042–1052
  11. Jensen JT, Zelinski-Wooten MB, Schwinof KM, et al. The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation during gonadotropin-stimulated ovarian cycles in rhesus macaques. Contraception. 2005;71:68–73
  12. Jensen JT, Zelinski MB, Stanley JE, et al. The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation in the naturally selected dominant follicle in rhesus macaques. Contraception. 2008;77:303–307
  13. Wolf DP, Thomson JA, Zelinski-Wooten MB, et al. In vitro fertilization–embryo transfer in nonhuman primates: the technique and its applications. Mol Reprod Dev. 1990;27:261–280
  14. Young KA, Hennebold JD, Stouffer RL. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. Mol Hum Reprod. 2002;8:833–840
  15. Zelinski-Wooten MB, Slayden OD, Chwalisz K, et al. Chronic treatment of female rhesus monkeys with low doses of the antiprogestin ZK 137 316: establishment of a regimen that permits normal menstrual cyclicity. Hum Reprod. 1998;13:259–267
  16. Tarantal AF, Laughlin LS, Dieter J, et al. Pregnancy detection by ultrasound and chorionic gonadotropin during the peri-implantation period in the macaque (Macaca fascicularis). Early Pregnancy. 1997;3:281–290
  17. Zelinski-Wooten MB, Chwalisz K, Iliff SA, et al. A chronic, low-dose regimen of the antiprogestin ZK 137 316 prevents pregnancy in rhesus monkeys. Hum Reprod. 1998;13:2132–2138
  18. Lahteenmaki PL, Lahteenmaki P. Concentration-dependent mechanisms of ovulation inhibition by the progestin ST-1435. Fertil Steril. 1985;44:20–24
  19. World Health Organization . In: Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. 3rd ed.. Geneva: WHO; 2003;p. 176
  20. Billington CK, Joseph SK, Swan C, et al. Modulation of human airway smooth muscle proliferation by type 3 phosphodiesterase inhibition. Am J Physio. 1999;276:L412–L419
  21. Cone J, Wang S, Tandon N, et al. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovas Pharmacol. 1999;34:497–504
  22. El-Metwally M, Shafiee-Nick R, Pyne NJ, et al. The effect of selective phosphodiesterase inhibitors on plasma insulin concentrations and insulin secretion in vitro in the rat. Eur J Pharmacol. 1997;324:227–232
  23. Moberg E, Enoksson S, Hagstrom-Toft E. Importance of phosphodiesterase 3 for the lipolytic response in adipose tissue during insulin-induced hypoglycemia in normal man. Horm Metabo Rese. 1998;30:684–688
  24. Movsesian MA, Alharethi R. Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy. Expert Opin Investig Drugs. 2002;11:1529–1536
  25. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiolo Rev. 1995;75:725–748
  26. Manganiello VC, Taira M, Degerman E, et al. Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell Signalling. 1995;7:44555
  27. Conti M, Nemoz G, Sette C, et al. Recent progress in understanding the hormonal regulation of phosphodiesterases. Endoc Rev. 1995;16:370–389

☆ This research was supported by the Eunice Kennedy Shriver NICHD through R01-042710 and by U54 HD18185, U54 HD 031398 and NCRR RR00163.

PII: S0010-7824(09)00446-6

doi: 10.1016/j.contraception.2009.09.015

Contraception
Volume 81, Issue 2 , Pages 165-171 , February 2010

Article Tools

* Image Usage & Resolution